Tyers Asset Management’s NovoCure NVCR Stock Holding History

Tyers Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,154	Closed	-$243K	–	983
2018 Q1	$243K	Hold	11,154	–	–	0.01%	621
2017 Q4	$225K	Hold	11,154	–	–	0.01%	653
2017 Q3	$221K	Hold	11,154	–	–	0.01%	607
2017 Q2	$193K	Hold	11,154	–	–	0.01%	610
2017 Q1	$90K	Hold	11,154	–	–	﹤0.01%	698
2016 Q4	$88K	Buy	+11,154	New	+$89.7K	﹤0.01%	675

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Tyers Asset Management's NVCR Position: Q2 2018 in Review

Tyers Asset Management sold out of NovoCure (NVCR) in Q2 2018, closing a stake of 11,154 shares — an estimated $243K sold.

Tyers Asset Management first reported a position in NVCR in Q4 2016 and held it in 6 quarters. The position peaked at $243K in Q1 2018. 161 funds tracked by Wall St. Rank hold NVCR as of Q2 2018.

Tyers Asset Management reported no remaining NovoCure position as of Q2 2018 after selling out during the quarter.
Tyers Asset Management sold 11,154 NovoCure shares in Q2 2018, an estimated $243K.
Tyers Asset Management first reported a position in NovoCure in Q4 2016 and held it in 6 quarters.
Tyers Asset Management's NovoCure position peaked at $243K in Q1 2018.
161 funds tracked by Wall St. Rank held NovoCure as of Q2 2018.

Based on Tyers Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.